Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biological Mimetics, Inc.,

Biological Mimetics, Inc. (“BMI”) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine.
Our mission philosophy is to remain a creative and innovative biotechnology firm dedicated to improving the quality of life and overall state of public health through the application of novel technologies for the development and commercialization of human and veterinary biologics to address a long list of hitherto intractable disease targets involving viruses, bacteria, parasites, and cancer.

Based on the Company’s elucidation of a common vaccine evading mechanism of antigenic variation known as “Deceptive Imprinting” used by microbial pathogens and cancer cells, the company has developed a proprietary core technology termed “Immune Dampening and Refocusing”, which uses immune dampening and refocusing to circumvent such evasion mechanisms to: (1) generate vaccines against pathogens for which no effective vaccine exists and (2) improve on the strain or serotype restricted protection of previously tried and currently licensed and used human and veterinary vaccines. In addition, the technology is able to alter the natural antigenicity and immunogenicity of targeted protein antigens to induce and select for unique monoclonal antibodies that can be used for therapeutic, diagnostic, and research purposes. Therapeutic proteins and biologics can also be immune dampened to improve on their biological half-life and safety profiles.


Contact Details:
124 Byte Drive,
Frederick
Maryland
21702
United States of America
Tel:(301) 620-7565
Fax:(301) 620-1827
Email:info@bmi-md.com
WWW:

www.bmi-md.com/




Loading...

BioNews Results for Biological Mimetics, Inc.,:

US FDA committee backs Pfizer's invasive pneumococcal disease vaccine, Prevnar for kids
PharmaBiz:  Nov 23 2009 4:13AM Matching: biological inc
Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science &
PR Newswire:  Nov 23 2009 12:45AM Matching: biological inc
Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science &
Genetic Engineering News:  Nov 21 2009 4:46AM Matching: biological inc
Medical device company ART reaches restructuring proposal after review
Bioscience Technology Online:  Nov 21 2009 2:07AM Matching: biological inc
FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13„ Vaccine for the
PharmaceuticalProcessing:  Nov 20 2009 8:26PM Matching: biological inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Biological Mimetics, Inc., news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 331 times since April 2007, the link to the organisation's website has been followed 81 times

Recent Search Terms used to find this page: Biological Mimetics | biological mimetics | what are biological mimetics | .

Search for more companies in Frederick

Search for more companies in Maryland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biological Mimetics, Inc.,

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.